Navigation Links
Edwards' Resilient Trial Demonstrates Statistically Superior Results for Treating Peripheral Arterial Disease in the Leg
Date:10/23/2007

fesciences

Edwards Lifesciences, a leader in advanced cardiovascular disease treatments, is the number-one heart valve company in the world and the global leader in acute hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards focuses on specific cardiovascular opportunities including heart valve disease, peripheral vascular disease and critical care technologies. The company's global brands, which are sold in nearly 100 countries, include Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, LifeStent, PERIMOUNT Magna, and Swan-Ganz. Additional company information can be found at http://www.edwards.com.

This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements include, but are not limited to, those related to the expectation that the results from The RESILIENT Trial will establish the LifeStent self-expanding stent as a treatment alternative for certain patients. Forward-looking statements are based on estimates and assumptions made by management of the company and are believed to be reasonable, though they are inherently uncertain and difficult to predict.

Forward-looking statements involve risks and uncertainties that could cause actual results or experience to differ materially from that expressed or implied by the forward-looking statements. Factors that could cause actual results or experiences to differ materially from that expressed or implied by the forward-looking statements include those risks detailed in the company's filings with the Securities and Exchange Commission including its Annual Report on Form 10-K for the year ended December 31, 2006.

Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences, Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz are trademar
'/>"/>

SOURCE Edwards Lifesciences Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
3. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
4. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
5. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
6. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
7. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
8. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
9. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... Pharmaceutical Care Management Association (PCMA) President and CEO ... reduce prescription fraud and abuse in Medicare Part D ... Fighting Back on Many Fronts ," sponsored by the ... The briefing featured several government and industry experts discussing ... Centers for Disease Control and Prevention has labeled the ...
(Date:9/29/2014)... CITY , Sept. 29, 2014 ... scheduled a conference call for investors today at ... the quarter and year ended June 30, 2014.  ... participating is (800) 771-7941. Dynatronics manufactures, ... goods and supplies, treatment tables and rehabilitation equipment ...
(Date:9/29/2014)... 2014 EU5 Esophagoscopes & Gastroscopes Market ... report, "EU5 Esophagoscopes & Gastroscopes Market Outlook to ... Esophagoscopes & Gastroscopes market. The report provides value, ... and average prices (in US dollars) within market ... Gastroscopes and Flexible Video Gastroscopes. ...
Breaking Medicine Technology:PCMA: How Congress Can Fight Prescription Drug Fraud and Abuse 2EU5 Esophagoscopes & Gastroscopes Market Outlook to 2020 2EU5 Esophagoscopes & Gastroscopes Market Outlook to 2020 3
(Date:9/30/2014)... Pyramid Analytics, worldwide leader in Governed ... of Veterans Affairs has selected Pyramid Analytics ... Business Intelligence platform. This partnership will enable the ... enabling more than 30,000 users with insights that ... and reporting capabilities. , The strategic selection comes ...
(Date:9/30/2014)... “Biology and botany are having ... “and it’s about naming rights.” , In ... on the Bryan William Brickner Blog, the focus ... of Health (PubMed). The post highlights five cannabinoid ... transitions, aging with THC, the wake-inducing effects of ...
(Date:9/30/2014)... September 30, 2014 A trailblazer at heart, ... seeks out upcoming medical breakthroughs in spine repairs. His ... seen in his patients in which he has implanted the ... its components are state-of-the art and mimic normal human disc ... has also been proven to be an exceptional replacement device ...
(Date:9/30/2014)... 30, 2014 3M has added four new ... bond tapes. 3M 5906 , 3M 5907 , ... conformable VHBs which help create the strongest bond possible to ... used for bonding to difficult surfaces such as paints, low ... 5907, 5908, and 5905 are designed specifically for electronic device ...
(Date:9/30/2014)... Dogs are social animals, and love to go everywhere with ... travelling from place to place. Many dog owners choose to ... this is not only unsafe for the dog, but unsafe ... shares with readers why keeping a dog restrained in a ... ways a dog can become injured by riding freely in ...
Breaking Medicine News(10 mins):Health News:U.S. Department of Veterans Affairs Takes Its Analytic Capabilities to the Next Level with BI Office from Pyramid Analytics 2Health News:Homeostasis: Publius’ Sleep Political Cannabinoid Science ~ New on the Bryan William Brickner Blog 2Health News:3M Releases New VHB™ Thin Foam Tapes as the Ultimate Electronics Bonding Solution 2Health News:3M Releases New VHB™ Thin Foam Tapes as the Ultimate Electronics Bonding Solution 3Health News:Royal Flush Havanese Offers Tops On the Importance of Restraining Dogs In Cars 2Health News:Royal Flush Havanese Offers Tops On the Importance of Restraining Dogs In Cars 3
... June 7th, Little Hearts, Inc. held their 13th annual celebration ... services they offer is their "Picture of Hope" -- a ... from infant to 50 of all different types of heart ... and Tricuspid Atresia. "HOPE" is shared with others on ...
... two hours of slumber a night, study suggests , MONDAY, ... computer games can be a nocturnal nightmare for some people, ... sleep at night, then spend their days struggling to stay ... between the two, the study found. , The study revealed ...
... 8 Taste and nutrition have long been topics ... so much uncertainty about what products are healthy in ... way by delivering delicious, convenient and nutritious foods to ... the release of Sunsweet Antioxidant Blend, a delicious combination ...
... the Shelves for Father,s Day , , NEW YORK, June ... back pain may lie in a $59.99 biomechanically-engineered foam and rubber ... point for the sixty million adults who reported persistent back pain ... to be a medical breakthrough is now available in the Dass, ...
... -- Eating disorders are a chronic mental health ... 1 million males in the United States. Through access ... organizations (IROs) provide a simple and lasting solution to ... and laxative abuse. Additionally they deliver the appropriate standard ...
... Cedars-Sinai Outpatient Cancer Center Appointed COO , , ... today announced the appointment of Paul R. O,Dea to ... formerly Vice President, Aptium Oncology and Executive Director, Cedars-Sinai ... hospital-based cancer centers. The appointment was effective June 1, ...
Cached Medicine News:Health News:Members of National CHD Organization Unite for Little Hearts' Celebration and Assemble for 'Picture of Hope' 2Health News:Too Much Computer Gaming Can Steal Your Sleep 2Health News:Too Much Computer Gaming Can Steal Your Sleep 3Health News:Sunsweet Introduces New Antioxidant Blend, a Delicious Blend of High Antioxidant Fruits 2Health News:Sunsweet Introduces New Antioxidant Blend, a Delicious Blend of High Antioxidant Fruits 3Health News:One of Women's Best Kept Secrets is Now Available in the Men's Department 2Health News:Health Plans and IROs Can Work Together to Determine Proper Care for Eating Disorders 2Health News:Aptium Oncology Names New Chief Operating Officer 2
... Elite II features a diagnostic ... of Glasgow,(UG) algorithm. Unlike competitive ... age, the UG,algorithm bases its ... gender, age, race, medication,and classification., ...
... test face is a LogMAR ... Landolt C in various orientations ... targets are presented at 10% ... useful for evaluating the low ...
The CSV-1000-1.5CPD is a special test face designed specifically for Food and Drug Administration clinical trials., ,At the recommended test distance of 8 feet, the gratings test one spatial frequenc...
... test face is used widely for screening ... LogMAR acuity from 20/10 to 20/100 and ... cycles/degree. , ,The patient can be easily ... acuity and contrast sensitivity. If a contrast ...
Medicine Products: